Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

According to the Venous Blood HBsAg State of Neonatus at Birth, Discussing the Efficiency of Personalized Blocking Method of HBV Maternal-neonatal Transmission in High-risk Newborns

NCT02901418 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT02901418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02901418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
According to the Venous Blood HBsAg State of Neonatus at Birth, Discussing the Efficiency of Personalized Blocking Method of HBV Maternal-neonatal Transmission in High-risk Newborns
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2015
Completion date
June 30, 2018
Enrollment
406 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b